Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 1861-1868

  Kirikae, Teruo ^a   Hirata, Michimasa ^b   Yamasu, Hiromi ^a   Kirikae, Fumiko ^a   Tamura, Hiroshi ^c   Kayama, Fumio ^a   Nakatsuka, Keisuke ^a   Yokochi, Takashi ^d   Nakano, Masayasu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c SEIKAGAKU CORPORATION   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BETA 1,3 GLUCAN; CEFTAZIDIME; ENDOTOXIN; GALACTOSAMINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL STRAIN L 929; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTOXEMIA; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER SLICE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SALMONELLA MINNESOTA; SEPTIC SHOCK; SEPTICEMIA;

EID: 0031925180     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.1861-1868.1998     Document Type: Article

References (46)

1. Alexander, H. L., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia. J. Exp. Med. 173:1029-1036.
2. Aley, S. B., M. Zimmerman, M. Hetsko, M. E. Selsted, and F. D. Gillin. 1994. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect. Immun. 62:5397-5403.
3. Ashkenazi, A., A. S. Marsters, D. J. Capon, S. M. Chamow, I. S. Figari, D. Pennica, D. V. Goeddel, M. A. Palladino, and D. H. Smith. 1991. Protection against endotoxin shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88:10535-10540.
4. Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Boca Raton, Fla.
5. Bucklin, S. E., and D. C. Morrison. 1995. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172:1519-1527.
6. Cerami, A., and B. Beutler. 1988. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 9:28-31.
7. Christ, W. J., O. Asano, A. L. C. Robidoux, M. Ferez, Y. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. McGuinness, M. A. Mullarkey, M. D. Lewis, Y. Kishi, T. Kawata, J. R. Bristol, J. R. Rose, D. P. Rossignol, S. Kobayashi, I. Hishumura, A. Kimura, N. Asakawa, K. Katayama, and I. Yamatsu. 1995. E5531, a pure endotoxin antagonist of high potency. Science 268:80-83.
8. Del Sal, G., P. Storici, C. Sehnender, D. Romeo, and M. Zanetti. 1992. cDNA cloning of the netrophil bactericidal peptide indolicin. Biochem. Biophys. Res. Commun. 187:467-472.
9. Elsbach, P., J. Weiss, R. C. Franson, A. Beckerdite-Quagliata, A. Schneider, and L. Harris. 1979. Separation and purification of a potent bactericidal/permeability increasing protein and a closely related phospholipase A2 from PMNs: observation on their relationship. J. Biol. Chem. 254:11000-11008.
10. Flegel, W. A., M. W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 61: 5140-5146.
11. Galanos, C., M. A. Freudenberg, and W. Reuter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 75:5939-5943.
12. Gazzano-Santoro, H., J. B. Parent, L. Grinna, A. Horwitz, T. Persons, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60:4754-4761.
13. Hirata, M., Y. Shimomura, M. Yoshida, J. G. Morgan, I. Palings, D. Wilson, M. H. Yen, S. C. Wright, and J. W. Larrick. 1994. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun. 62:1421-1426.
14. Hirata, M., Y. Shimonura, M. Yoshida, S. C. Wright, and J. W. Larrick. 1994. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities, p. 147-159. In J. Levin, S. J. H. van Deventer, T. van der Poll, and A. Sturk (ed.). Bacterial endotoxin: basic science to anti-sepsis strategies. Wiley-Liss, Inc., New York, N.Y.
15. Hirata, M., S. C. Wright, and J. W. Larrick. 1996. Endotoxin-neutralizing proteins for sepsis and endotoxin shock, p. 109-115. In K. Okada and H. Ogata (ed.), Shock. Elsevier Science, B.V., Amsterdam.
16. Hirata, M., M. Yoshida, K. Inada, and T. Kirikae. 1990. Investigation of endotoxin binding cationic proteins from granulocyte. Agglutination of erythrocytes sensitized with Re-LPS. Adv. Exp. Med. Biol. 256:287-299.
17. Hirata, M., J. Zhong, S. C. Wright, and J. W. Larrick. 1995. Structure and functions of endotoxin-binding peptides derived from CAP18, p. 317-326. In J. Levin, C. R. Alving, R. S. Munford, and H. Redl (ed.), Bacterial cndotoxins: lipopolysaccharides from genes to therapy. Wiley-Liss, Inc., New York, N.Y.
18. Hitchcock, P. J., L. Leive, P. H. Makela, E. T. Rietschel, W. Stritimatter, and D. C. Morrison. 1986. Lipopolysaccharide nomenclature - past, present, and future. J. Bacteriol. 166:699-705.
19. Jackson, J. J., and H. Kropp. 1996. Differences in mode of action of β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. J. Endotoxin Res. 3:201-218.
20. Kayama, F., T. Yoshida, M. R. Elwell, and M. I. Luster. 1995. Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131:224-234.
21. Kirikae, F., T. Kirikae, N. Qureshi, K. Takayama, D. C. Morrison, and M. Nakano. 1995. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect. Immun. 63:486-497.
22. Kirikae, T., M. Nakano, and D. C. Morrison. 1997. Antibiotic-induced endotoxin release from bacteria and its clinical significance. Microbiol. Immunol. 41:285-294.
23. Larrick, J. W., M. Hirata, R. F. Balint, T.-H. Huang, C. Chen, J. Zhong, and S. Wright. 1996. CAP18: a novel LPS-binding/antimicrobial protein, p. 71 95. In D. C. Morrison and J. L. Ryan (ed.), Novel therapeutic stratiagies in the treatment of sepsis. Marcel Dekker, Inc., New York, N.Y.
24. Larrick, J. W., M. Hirata, R. F. Balint, J. Lee, J. Zhong, and S. C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
25. Larrick, J. W., M. Hirata, Y. Shimomura, M. Yoshida, H. Zheng, J. Zhong, and S. C. Wright. 1993. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob. Agents Chemother. 37:2534-2539.
26. Larrick, J. W., M. Hirata, H. Zheng, J. Zhong, D. Bolin, J. M. Cavaillon, H. S. Warren, and S. C. Wright. 1994. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 152:231-240.
27. Larrick, J. W., J. G. Morgan, I. Palings, M. Hirata, and M. H. Yen. 1991. Complementary DNA sequence of rabbit CAP18. A unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179:170-175.
28. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657-663.
29. Lehrer, R. I., A. K. Lichtenstein, and T. Ganz. 1993. Defensins: antimicrobial and cytotoxic peptide of mammalian cells. Annu. Rev. Immunol. 11:105-128.
30. Marra, M. N., C. G. Wilde, M. S. Collins, J. L. Snabel, M. B. Thronton, and R. W. Scott. 1992. The role of BPI as a natural inhibitor of bacterial endotoxin. J. Immunol. 148:532-540.
31. Morrison, D. C. 1997. Antibiotics, endotoxin, and the pathogenesis of gramnegative sepsis, p. 1-4. In 4th International Congress on the Immune Consequences of Trauma, Shock, and Sepsis. Merck & Co., Inc., Whitehouse Station, N.J.
32. Morrison, D. C. 1996. Endotoxin/antibiotics and gram-negative sepsis. J. Endotoxin Res. 3:171.
33. Morrison, D. C., S. E. Bucklin, M. C. Leeson, and M. Norimatsu. 1996. Contribution of soluble endotoxin released from Gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice. J. Endotoxin Res. 3:237-243.
34. Morrison, D. C., R. L. Danner, C. A. Dinarello, R. S. Munford, C. Natanson, M. Pollack, J. J. Spitzer, R. J. Ulevitch, S. N. Vogel, and E. McSweegan. 1994. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J. Endotoxin Res. 1:71-83.
35. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
36. Nakano, M., and T. Kirikae. 1996. Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro. J. Endotoxin Res. 3:195-200.
37. Neu, H. C. 1985. Relation of structural properties of β-lactam antibiotics to antibacterial activity. Am. J. Med. 79:2-13.
38. Radermacher, S. W., V. M. Schoop, and H. J. Schluesener. 1993. Bactenecin, a leukocytic antimicrobial peptide, is cytotoxic to neuronal and glial cells. J. Neurosci. Res. 36:657-662.
39. Rietschel, E. T., H. Brade, O. Holst, L. Brade, S. Müller-Loennies, U. Mamat, U. Zähringer, F. Beckmann, U. Seydel, K. Brandenburg, A. J. Ulmer, T. Mattern, H. Heine, J. Schletter, H. Loppnow, U. Schönbeck, H.-D. Flad, and S. Hauschildt. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216:39-81.
40. Schluesener, H. J., S. Radermacher, A. Melms, and S. Jung. 1993. Leucocytic antimicrobial peptides kill autoimmune T cells. J. Neuroimmunol. 47: 119-202.
41. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
42. Shafer, W. M., L. E. Martin, and J. K. Spitznage. 1984. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fiuorophosphates. Infect. Immun. 45:29-35.
43. Tanaka, S., and S. Iwanaga. 1993. Limulus test for detecting bacterial endotoxins. Methods Enzymol. 223:358-364.
44. Tuomanen, E., K. Gilbert, and A. Tomasz. 1986. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins la and 3 in Escherichia coli. Antimicrob. Agents Chemother. 30:659-663.
45. VanderMerr, T. J., M. J. Menconi, J. Zhuang, H. Wang, R. Murtaugh, C. Bouza, P. Stevens, and M. P. Fink. 1995. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. Surgery 117:656-662.
46. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.